[DISCLOSURE] Celltrion (068270) announced on Aug. 29 that it has obtained a patent on CT-P23, a human monoclonal antibody for treatment of Influenza A virus.
Celltrion obtains patent for Influenza A antibody
Published : Aug. 29, 2016 - 15:28:38
Published : Aug. 29, 2016 - 15:28:38
[DISCLOSURE] Celltrion (068270) announced on Aug. 29 that it has obtained a patent on CT-P23, a human monoclonal antibody for treatment of Influenza A virus.